THE IMPACT OF PHARMACEUTICAL CARE ON THE PREVENTION OF CHRONIC DISEASES

Abstract

Non-communicable chronic diseases (NCDs), such as hypertension, diabetes, and cardiovascular diseases, represent one of the greatest challenges for global and national health systems, accounting for over 70% of deaths worldwide. This study aimed to analyze the impact of pharmaceutical care on the prevention and control of NCDs, highlighting its clinical, social, and economic benefits. Through a systematic literature review based on the PRISMA methodology and using search strategies in the PubMed, LILACS, and BVS databases, articles published between 2019 and 2025 were selected, focusing on pharmaceutical interventions applied to chronic patients. The results show that pharmaceutical care, when integrated into Primary Health Care (PHC), promotes significant improvements in clinical indicators, such as blood glucose and blood pressure control, increased adherence to medication treatment, and reduction of adverse events and preventable hospitalizations. Furthermore, social benefits are observed, such as the strengthening of the bond between patients and healthcare professionals, as well as economic benefits, with the optimization of public system resources. Despite these advances, the study identified limitations such as a shortage of pharmacists, gaps in clinical training, and lack of institutional recognition. Therefore, it reinforces the importance of valuing the pharmacist as a clinical agent, expanding public policies aimed at preventive health, and conducting future research with greater methodological rigor. Pharmaceutical care proves to be an effective, sustainable, and patient-centered strategy with transformative potential in addressing chronic diseases.